Skip to main content
MEHA
NASDAQ Life Sciences

Functional Brands Repurchases $622K in Preferred Stock to Reduce Dilution

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$0.199
Mkt Cap
$3.245M
52W Low
$0.18
52W High
$8
Market data snapshot near publication time

summarizeSummary

Functional Brands Inc. repurchased 12,445 shares of Series A Convertible Preferred Stock for $622,250, aiming to reduce potential dilution and strengthen its capital structure.


check_boxKey Events

  • Significant Preferred Stock Repurchase

    Functional Brands Inc. repurchased 12,445 shares of its Series A Convertible Preferred Stock for $622,250 from Evergreen Capital Management LLC.

  • Dilution Reduction Strategy

    The repurchase, funded by working capital, is part of ongoing efforts to reduce potential dilution, with the acquired shares slated for cancellation.

  • Follows Prior Repurchase

    This marks the second significant repurchase of Series A Preferred Stock in recent weeks, following a $180,330 repurchase on January 5, 2026.

  • Future Common Stock Resale Registration

    As part of the agreement, the company committed to filing an S-1 registration statement for the resale of up to 171,000 shares of common stock held by the seller.


auto_awesomeAnalysis

This significant repurchase of Series A Convertible Preferred Stock, valued at $622,250, represents a substantial portion of Functional Brands' market capitalization. This action is a strategic move to reduce potential dilution and clean up the company's capital structure. Coming shortly after a previous preferred stock repurchase on January 5, 2026, and amidst a Nasdaq deficiency notice received on January 2, 2026, this signals the company's commitment to improving its financial health and addressing factors that could impact its stock price. The cancellation of these shares will reduce future conversion risk. However, the agreement also includes a commitment to file an S-1 for the seller to resell common stock, which could introduce future selling pressure.

At the time of this filing, MEHA was trading at $0.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $0.18 to $8.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MEHA - Latest Insights

MEHA
Apr 27, 2026, 4:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
MEHA
Apr 22, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
MEHA
Apr 13, 2026, 4:10 PM EDT
Filing Type: PRE 14A
Importance Score:
9
MEHA
Mar 30, 2026, 10:14 AM EDT
Filing Type: 8-K
Importance Score:
9
MEHA
Mar 27, 2026, 5:08 PM EDT
Filing Type: 10-K
Importance Score:
9
MEHA
Mar 20, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
MEHA
Mar 13, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
9
MEHA
Feb 23, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
MEHA
Feb 06, 2026, 8:12 PM EST
Filing Type: 8-K
Importance Score:
8
MEHA
Feb 04, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8